86300715 - ATGEN

Information

• Trademark
• 86300715

• Source

• Serial Number

  86300715

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 35 - Advertising
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  June 04, 2014
  10 years ago

• Transaction Date

  February 05, 2019
  5 years ago

• Status Date

  February 05, 2019
  5 years ago

• Published for Opposition Date

  May 26, 2015
  9 years ago

• Location Date

  February 05, 2019
  5 years ago

• Status Code

  604

• Current Location

  TTAB

  Employee Name

  SONNEBORN, TRICIA L

• Attorney Docket Number

  97060-910630

  Attorney Name

  Margaret C. McHugh

  Law Office Assigned Location Code

  M10

• Owners

  • ATGen Co., Ltd.

Case File Statements

• CC0000: Color is not claimed as a feature of the mark.
• DM0000: The mark consists of a double helix spanning horizontally above the word "ATGen" in front of two concentric circles.
• GS0011: Proteins in raw material form for scientific and medical research; Proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens and antibodies for use by others in manufacturing pharmaceutical and veterinary preparations; proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens and antibodies for scientific and research purposes; diagnostic kits for clinical laboratory use, namely kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status diagnostic kits for medical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for clinical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA in disease diagnosis screening, and immune status; diagnostic preparations for clinical laboratory use and medical laboratory use; diagnostic preparations for clinical research use other than for medical use; diagnostic reagents for clinical laboratory use, medical laboratory use, medical research use and clinical research use
• GS0051: Proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones for veterinary or medical purposes: hormones; diagnostic kits for medical diagnostic use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic activators in the nature of proteins for use in diagnostic kits for disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for medical diagnostic use; diagnostic reagents for medical diagnostic use
• GS0351: Online retail store services featuring proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones; online retail store services featuring vitro diagnostic devices and antibody detection kits
• GS0401: Custom manufacture of proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones; Custom manufacture of in vitro diagnostic devices and antibody detection kits
• GS0421: medical research services; scientific research, namely, conducting clinical research trials; research and development of medicines based on protein and peptide therapeutic applications; medical diagnostic services; biological DNA cloning services; protein expression services in the field of biotechnology, namely, DNA gene cloning services, purification process development; laboratory services relating to the production of monoclonal antibodies; medical and scientific research services, namely, monoclonal antibody development, generation and screening and design related thereto
• PM0000: AT GEN

Case File Event Statements

• 2/5/2019 - 5 years ago

  23 - ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION Type: MAB4

• 2/5/2019 - 5 years ago

  22 - ABANDONMENT - AFTER INTER PARTES DECISION Type: ABN4

• 2/5/2019 - 5 years ago

  21 - OPPOSITION TERMINATED NO. 999999 Type: OP.T

• 2/5/2019 - 5 years ago

  20 - OPPOSITION DISMISSED NO. 999999 Type: OP.D

• 12/2/2016 - 8 years ago

  19 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 9/22/2015 - 9 years ago

  18 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I

• 6/22/2015 - 9 years ago

  17 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF

• 5/26/2015 - 9 years ago

  16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 5/26/2015 - 9 years ago

  15 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/6/2015 - 9 years ago

  14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 4/17/2015 - 9 years ago

  13 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 4/14/2015 - 9 years ago

  12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 3/19/2015 - 9 years ago

  11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/19/2015 - 9 years ago

  10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/12/2015 - 9 years ago

  9 - ASSIGNED TO LIE Type: ALIE

• 3/4/2015 - 9 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/22/2014 - 10 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/22/2014 - 10 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 9/22/2014 - 10 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/16/2014 - 10 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 6/18/2014 - 10 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSM

• 6/17/2014 - 10 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 6/7/2014 - 10 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP